Regencell Bioscience Holdings Ltd
For the period ended Jun 30, 2025. Filed Jun 30, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2025 · Filed Jun 30, 2025
Use the contents to explore the available documents and sections.
RGC$5.270.0%Stored close · as of Nov 6, 2026
Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Regencell Bioscience Holdings Limited | ||
| By: | /s/ Yat-Gai Au | |
| Name: | Yat-Gai Au | |
| Title: | Chief Executive Officer and Chairman of the Board of Directors | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.